Rainbow Children's Medicare Limited (NSE:RAINBOW)
1,525.00
+4.40 (0.29%)
Jul 31, 2026, 3:30 PM IST
NSE:RAINBOW Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, NSE:RAINBOW stock has a consensus rating of "Strong Buy" and an average price target of ₹1,682. The average 1-year stock price forecast is 10.27% higher than the current stock price, while the lowest is ₹1,500 (-1.64%) and the highest is ₹2,000 (+31.15%).
Price Target: ₹1,682 (+10.27%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 10, 2026.
Analyst Ratings
The average analyst rating for NSE:RAINBOW stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 10 | 10 | 10 |
| Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Prabhudas Lilladher | Prabhudas Lilladher | Buy Maintains ₹1,615 → ₹1,700 | Buy | Maintains | ₹1,615 → ₹1,700 | +11.48% | Jun 10, 2026 |
| Geojit Research | Geojit Research | Buy Initiates ₹1,679 | Buy | Initiates | ₹1,679 | +10.10% | May 27, 2026 |
Financial Forecast
Revenue This Year
20.04B
from 17.03B
Increased by 17.66%
Revenue Next Year
23.16B
from 20.04B
Increased by 15.56%
EPS This Year
32.43
from 27.53
Increased by 17.79%
EPS Next Year
37.94
from 32.43
Increased by 17.01%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.